NCT04798690 Long-term Safety and Effectiveness of Growtropin®-II Treatment in Children With Short Stature
| NCT ID | NCT04798690 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Dong-A ST Co., Ltd. |
| Condition | Growth Hormone Deficiency |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,500 participants |
| Start Date | 2021-02-08 |
| Primary Completion | 2031-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,500 participants in total. It began in 2021-02-08 with a primary completion date of 2031-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study evaluates long-term safety and effectiveness of Growtropin®-II treatment in children with short stature.
Eligibility Criteria
Inclusion Criteria: * Children with short stature by growth hormone deficiency(GHD) or idiopathic short stature (ISS) or turner's syndrome(TS) or small for gestational age(SGA) * Children who has official height record at least 6 months prior Exclusion Criteria: * Children with Epiphyseal closure
Contact & Investigator
Frequently Asked Questions
Who can join the NCT04798690 clinical trial?
This trial is open to participants of all sexes, aged 2 Years or older, studying Growth Hormone Deficiency. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04798690 currently recruiting?
Yes, NCT04798690 is actively recruiting participants. Contact the research team at jhsung@donga.co.kr for enrollment information.
Where is the NCT04798690 trial being conducted?
This trial is being conducted at Seoul, South Korea.
Who is sponsoring the NCT04798690 clinical trial?
NCT04798690 is sponsored by Dong-A ST Co., Ltd.. The trial plans to enroll 2,500 participants.